The Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has made a public position disclosure under Rule 8.3 of the UK Takeover Code. The disclosure, dated August 18, 2026, pertains to their interests in Spire Healthcare Group plc. As of August 17, 2026, Vanguard holds 14,366,796 ordinary shares in Spire, representing 3.57% of their 1p ordinary shares.

Vanguard also disclosed a recent transaction involving the purchase of 4,316 shares at a price of 2.35 GBP per share. No cash-settled or stock-settled derivative positions were present in the disclosure, and there were no indemnity or option arrangements identified. The disclosure was managed by Shawn Acker, serving as the contact for further inquiries.